Treatment of prostate cancer

被引:25
作者
Henry, RY [1 ]
O'Mahony, D [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Geriatr Med, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.1046/j.1365-2710.1999.00207.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prostate cancer is the leading cause of cancer death among older men in western countries. However, controversy surrounds many issues related to this disease, particularly its most appropriate treatment, with a wide spectrum of opinions ranging from watchful waiting to aggressive therapy. Patients with newly diagnosed prostate cancer, as well as their doctors, will have to make difficult decisions regarding treatment of this disease. In this article we discuss the current available treatment options and some novel therapeutic approaches to tackling the patient with prostate cancer.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 52 条
[1]   Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the Karolinska series [J].
Adolfsson, J ;
Steineck, G ;
Hedlund, PO .
UROLOGY, 1997, 50 (05) :722-726
[2]   Army and air force leadership in the prostate cancer prevention trial [J].
Allerton, J ;
Seay, T ;
Optenberg, S ;
Coltman, CA ;
Higgins, B ;
Thompson, I ;
Lovato, L .
UROLOGY, 1998, 51 (4A) :64-66
[3]  
[Anonymous], 1997, Br J Urol, V79, P235
[4]  
ARMSTRONG JG, 1998, IRISH MED TIMES 0501, P34
[5]  
AUSTENFELD MS, 1990, UROL CLIN N AM, V17, P867
[6]   Evaluation of ProstAsure index in the detection of prostate cancer: A preliminary report [J].
Babaian, RJ ;
Fritsche, HA ;
Zhang, Z ;
Zhang, KH ;
Madyastha, KR ;
Barnhill, SD .
UROLOGY, 1998, 51 (01) :132-136
[7]   Percent free prostate-specific antigen: The next frontier in prostate-specific antigen testing [J].
Beduschi, M ;
Oesterling, JE .
UROLOGY, 1998, 51 (5A) :98-109
[8]   Experience with low-dose oestrogen in the treatment of advanced prostate cancer: A personal view [J].
Bishop, MC .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (06) :921-927
[9]  
BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO
[10]  
2-C